Vote and Deadlines
Enumeration of Immunologically Defined Cell Populations by Flow Cytometry (H42-A2); Clinical Flow Cytometric Analysis of Neoplastic Hematolymphoid Cells (H43-A2)

CLSI submits the following for vote as candidate-for-advancement consensus documents.  The documents and ballots are available to delegates and alternates of Active and Associate Active member organizations through CLSI Forums.  

H42-A2—Enumeration of Immunologically Defined Cell Populations by Flow Cytometry; Approved Guideline – Second Edition
This document provides guidance for the immunophenotypic analysis of non-neoplastic lymphocytes by immunofluorescence-based flow cytometry; sample and instrument quality control; and precautions for acquisition of data from lymphocytes. The deadline for the completed ballot for H42-A2 to be received at the CLSI offices is 13 June 2006.

Second Notice

H43-A2—Clinical Flow Cytometric Analysis of Neoplastic Hematolymphoid Cells; Approved Guideline—Second Edition
This document provides performance guidelines for the immunophenotypic analysis of neoplastic hematolymphoid cells using immunofluorescence-based flow cytometry; for sample and instrument quality control; and precautions for acquisition of data from neoplastic hematolymphoid cells. The deadline for the completed ballot for H43-A2 to be received at the CLSI offices is 15 May 2006.

Under our Administrative Procedures, a CLSI document approved by the area committee at the first level of the consensus process is submitted to delegates as a “candidate-for-advancement” consensus document. This begins the voting and approval period by the delegates.

As a delegate, your vote is to affirm (or reject) the document for advancement as a CLSI document. Please send your completed ballot to the CLSI offices by the above deadline.

In the consensus process, comments are invited at each publication stage. In each edition, the responsible committee includes a summary of comments on the prior edition and its responses to them. Any comments received on a candidate-for-advancement consensus document as a result of delegate voting and consensus review will be addressed by the committee during the document’s advancement.

Find out more about Active and Associate Active membership. [ return to top ]